139 related articles for article (PubMed ID: 36053913)
1. Accuracy and validity of reported opioid prescription days' supply.
Miracle DK; Slavova S; Brown JR; Dasgupta N; Harris S; Freeman PR
Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1253-1261. PubMed ID: 36053913
[TBL] [Abstract][Full Text] [Related]
2. Mapping prescription drug monitoring program data to self-report measures of non-medical prescription opioid use in community pharmacy settings.
Charron E; Brooks JH; Peterson KT; Akinwolere OG; Winhusen T; Cochran G
Res Social Adm Pharm; 2023 Aug; 19(8):1171-1177. PubMed ID: 37142474
[TBL] [Abstract][Full Text] [Related]
3. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
[TBL] [Abstract][Full Text] [Related]
4. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
Manders L; Abd-Elsayed A
Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
[TBL] [Abstract][Full Text] [Related]
5. The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patterns.
Fleming JN; Zhang J; Taber DJ; McCauley JL; Schumann S; Mauldin PD; Ball S
J Am Pharm Assoc (2003); 2020; 60(4):559-564. PubMed ID: 32033899
[TBL] [Abstract][Full Text] [Related]
6. The effect of an opioid prescription days' supply limit on patients receiving long-term opioid treatment.
Yenerall J; McPheeters M
Int J Drug Policy; 2020 Mar; 77():102662. PubMed ID: 31968287
[TBL] [Abstract][Full Text] [Related]
7. Impact of prescription drug monitoring program mandate on postoperative opioid prescriptions in children.
Theodorou CM; Jackson JE; Rajasekar G; Nuño M; Yamashiro KJ; Farmer DL; Hirose S; Brown EG
Pediatr Surg Int; 2021 May; 37(5):659-665. PubMed ID: 33433663
[TBL] [Abstract][Full Text] [Related]
8. Association Between State Opioid Prescribing Limits and Duration of Opioid Prescriptions From Dentists.
Chua KP; Nguyen TD; Waljee JF; Nalliah RP; Brummett CM
JAMA Netw Open; 2023 Jan; 6(1):e2250409. PubMed ID: 36630136
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
[TBL] [Abstract][Full Text] [Related]
10. The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic.
Stein BD; Sheng F; Taylor EA; Dick AW; Sorbero M; Pacula RL
Drug Alcohol Depend; 2022 Feb; 231():109232. PubMed ID: 35007956
[TBL] [Abstract][Full Text] [Related]
11. Prescription drug monitoring programs in community pharmacy: An exploration of pharmacist time requirements and labor cost.
Upton C; Gernant SA; Rickles NM
J Am Pharm Assoc (2003); 2020; 60(6):943-950. PubMed ID: 32792293
[TBL] [Abstract][Full Text] [Related]
12. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
[TBL] [Abstract][Full Text] [Related]
13. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
Brown WC; Whitted K
J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
[TBL] [Abstract][Full Text] [Related]
14. Cycles of Chronic Opioid Therapy Following Mandatory Prescription Drug Monitoring Program Legislation: A Retrospective Cohort Study.
Allen B; Jent VA; Cerdá M
J Gen Intern Med; 2022 Dec; 37(16):4088-4094. PubMed ID: 35411535
[TBL] [Abstract][Full Text] [Related]
15. Assessing the impact of a restrictive opioid prescribing law in West Virginia.
Sedney CL; Khodaverdi M; Pollini R; Dekeseredy P; Wood N; Haggerty T
Subst Abuse Treat Prev Policy; 2021 Feb; 16(1):14. PubMed ID: 33526045
[TBL] [Abstract][Full Text] [Related]
16. Opioid Prescribing After Implementation of Single Click Access to a State Prescription Drug Monitoring Program Database in a Health System's Electronic Health Record.
Weiner SG; Kobayashi K; Reynolds J; Chan K; Kelly R; Wakeman S; Reddy P; Young LD
Pain Med; 2021 Oct; 22(10):2218-2223. PubMed ID: 33561288
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
[TBL] [Abstract][Full Text] [Related]
18. Differential patterns of opioid misuse between younger and older adults - a retrospective observational study using data from South Carolina's prescription drug monitoring program.
Zhang S; Silverman A; Suen SC; Andrews C; Chen BK
Am J Drug Alcohol Abuse; 2022 Sep; 48(5):618-628. PubMed ID: 36194086
[No Abstract] [Full Text] [Related]
19. Opioid dispensing and overlap in veterans with non-cancer pain eligible for Medicare Part D.
Suda KJ; Smith BM; Bailey L; Gellad WF; Huo Z; Burk M; Cunningham F; Stroupe KT
J Am Pharm Assoc (2003); 2017; 57(3):333-340.e3. PubMed ID: 28408172
[TBL] [Abstract][Full Text] [Related]
20. Association Between Statewide Opioid Prescribing Interventions and Opioid Prescribing Patterns in North Carolina, 2006-2018.
Maierhofer CN; Ranapurwala SI; DiPrete BL; Fulcher N; Ringwalt CL; Chelminski PR; Ives TJ; Dasgupta N; Go VF; Pence BW
Pain Med; 2021 Dec; 22(12):2931-2940. PubMed ID: 34175958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
